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Implantation of a transvenous endocardial pacing lead in the right ventricle is contra-
indicated after mechanical tricuspid valve replacement; therefore a surgical approach to the
epicardium is usually required. This case report describes ventricular pacing via a branch of
the coronary sinus in a patient with mechanical mitral, aortic and tricuspid valve
replacements. In conclusion, this approach is minimally invasive, provides eﬀective
ventricular stimulation with low pacing threshold and stable lead position, and is a feasible
option when transvenous right ventricular pacing is not possible.
(J Arrhythmia 2011; 27: 343–346)
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Introduction
In certain situations such as the presence of a
mechanical tricuspid prosthesis, endocardial pacing
of the right ventricle is not possible. We present a
case where we used a lead in the coronary sinus to
pace the left ventricle in a patient with bradycardia,
and 2 previous cardiac surgeries including tricuspid
valve replacement.
Case Report
A 66-year-old woman with a history of childhood
rheumatic fever underwent open mitral valvotomy in
1970. She re-presented in 1999 with moderate mixed
aortic valve disease, moderately severe mitral ste-
nosis and severe tricuspid regurgitation. Due to
progression of her symptoms from valvular heart
disease she underwent repeat surgery with triple
valve replacement in 2002 (aortic St. Jude (St. Paul,
MN, USA) 21mm prosthesis, mitral St. Jude 27mm
prosthesis and tricuspid St. Jude 33mm prosthesis).
Co-morbidities included longstanding persistent
atrial ﬁbrillation, Type 2 diabetes mellitus, gout,
gastritis and iron deﬁciency anaemia. She presented
in 2010 with palpitations and pre-syncope. ECG
monitoring showed atrial ﬁbrillation with occasion-
ally rapid ventricular rates and symptomatic 3.5
second pauses (Figure 1). To achieve satisfactory rate
control of atrial ﬁbrillation while preventing ven-
tricular pauses, a permanent ventricular pacemaker
was recommended.
After left subclavian vein access was achieved,
a guiding catheter (Boston Scientiﬁc, Boston, MA,
USA) was used to access the coronary sinus os,
which was situated inferomedially to the tricuspid
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valve prosthesis. A retrograde occlusion venogram
was acquired to assess target vessels. A Boston
Scientiﬁc Easytrak II ventricular lead was initially
placed in the posterolateral cardiac vein, but pacing
parameters were poor with high ventricular and low
diaphragmatic pacing thresholds. The middle cardiac
vein was cannulated by ‘‘double-wire’’ technique
where access to the coronary sinus is maintained by
one wire while the guide is withdrawn to the os of
the coronary sinus and the middle cardiac vein
oriﬁce probed for by a second wire (Glidewire,
Terumo Medical Corporation, Somerset, NJ, USA).
The pacing wire was introduced into a proximal
branch heading superiorly along the middle part of
the middle cardiac vein with the aid of an angio-
plasty wire. In this position we obtained excellent
pacing parameters (ventricular threshold 0.8 V at
0.5ms and diaphragmatic threshold 6.9V; R wave
20.1mV; impedance 1578 ohms; slew rate >4:0
V/s). The lead delivery system was slit and removed
without lead displacement, the lead secured to the
pectoral muscle fascia and attached to a Boston
Scientiﬁc Altrua 60 pulse generator. A chest x-ray
on the following day (Figure 2) showed good lead
position with no dislodgement, however the dia-
phragmatic pacing threshold had dropped to 2.5V
in some pacing conﬁgurations, so the output was
reduced to 2V while maintaining a 2.5-fold safety
margin for ventricular capture. A 12 lead ECG
showed left ventricular pacing on demand (Figure 3).
Discussion
In patients with tricuspid bioprostheses, endocar-
dial right ventricular lead placement is possible but
is associated with a signiﬁcant risk of lead fracture
at the valve site and valve damage may occur,
especially during lead extraction. In patients with
mechanical tricuspid valve prostheses, transvenous
pacing of the right ventricle may also cause valve
damage and failure and so is therefore contra-
indicated. One approach to pacing in this setting is
the consideration of epicardial pacing leads, which
requires a surgical technique involving a thoracot-
omy or sternotomy under general anaesthetic (a third
surgical procedure in our patient) and a resultant
longer hospital stay. This procedure is often techni-
cally challenging due to scar tissue and adhesions as
a result of previous surgery, and presents the added
risk of ventricular damage during dissection. Also
long-term epicardial pacing thresholds are inferior to
transvenous pacing thresholds and epicardial lead
failure rate is high 26% for epicardial leads
overall.1) In recent years, technological improve-
ments and the development of leads speciﬁcally
designed for left ventricular pacing have made left
Figure 1 Telemetry strips showing atrial ﬁbrillation with rapid ventricular response, complete heart block and
symptomatic pauses.
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ventricular capture and sensing a feasible alternative
where right ventricular pacing is not possible.
In 1970 Anagnostopoulos ﬁrst described the use of
the coronary sinus for intra-operative implantation
of pacemaker leads in patients with tricuspid valve
prostheses.2) Bai ﬁrst reported permanent transve-
nous left ventricular pacing via the great cardiac vein
in similar patients in 19943) and several other reports
Figure 2 PA and lateral chest X-ray 1 day after cardiac device implantation.
AVR: Aortic Valve Replacement, MVR: Mitral Valve Replacement, TVR: Tricuspid Valve Replacement
Figure 3 12 lead ECG showing left ventricular pacing.
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have since conﬁrmed the medium to long-term
success rate.4) This method has also been used
successfully in patients with complex congenital
heart disease with no venous access to the right
ventricle. Advantages of this approach are that it is
minimally invasive and provides eﬀective ventricu-
lar stimulation,5) and in addition a stable position in
a coronary vein with a reliably low threshold is
generally achievable. Complications of ventricular
pacing via the coronary sinus include diaphragmatic
stimulation, coronary sinus dissection and lead
displacement. The possibility of lead or delivery
system entanglement in the mechanical prosthesis
should be considered and avoided if at all possible.
Another factor to consider is the risk associated with
active ﬁxation left ventricular lead removal after
long-term implantation, should it become necessa-
ry.6) The potential complications of left ventricular
pacing via the coronary sinus must be considered in
comparison to a further major surgical procedure and
its associated risks. In the case we describe, a third
surgical procedure would have involved substantial
risks and increased morbidity, so ventricular pacing
via a branch of the coronary sinus was the preferred
approach.
In conclusion, pacemaker therapy after tricuspid
valve surgery still poses a considerable challenge.
Left ventricular pacing via the coronary sinus may
provide eﬀective ventricular stimulation with a low
threshold and stable lead position, and is a feasible
option when transvenous right ventricular pacing is
not possible.
References
1) Cohen MI, Bush DM, Vetter VL, et al: Permanent
epicardial pacing in pediatric patients: Seventeen years
of experience. Circulation 2001; 103: 2585–2590
2) Anagnostopoulos CE, Patel B, Fenn JE, et al: Transvenous
coronary sinus pacemaker. A new primary approach to
heart block in patients with tricuspid prostheses. Ann
Thorac Surg 1970; 9: 248–252
3) Bai Y, Strathmore N, Mond H, Grigg L, Hunt D:
Permanent ventricular pacing via the great cardiac vein.
Pacing Clin Electrophysiol 1994; 17: 678–683
4) Winter J, Gramsch-Zabel H, Furst G, Koch J,
Zimmermann N, Gams E: Long-term follow-up of left
ventricular pacing via a posterior cardiac vein after
mechanical tricuspid valve replacement. Pacing Clin
Electrophysiol 2001; 24: 125–126
5) Auricchio A, Stellbrink C, Butter C, Sack S, Vogt J,
Misier A, et al: Clinical eﬃcacy of cardiac resynchroni-
sation therapy using left ventricular pacing in heart failure
patients stratiﬁed by severity of ventricular conduction
delay. J Am Coll Cardiol 2003; 42: 2109–2116
6) Na¨gele H, Azizi M, Hashagen S, Castel MA, Behrens S:
First experience with a new active ﬁxation coronary sinus
lead. Europace 2007; 9: 437–441
J Arrhythmia Vol 27 No 4 2011
346
